To review outpatient rapid diagnostic testing (RDT) initiatives and identify specific gaps in the management of upper respiratory tract infections (URIs) to enhance antimicrobial stewardship.
Key Findings:
URIs account for 30% of outpatient antibiotic prescriptions, indicating a critical need for improved ASPs to address this issue.
Rapid diagnostic tests can significantly reduce unnecessary antimicrobial use by facilitating accurate diagnoses, with studies showing a reduction in prescriptions by X%.
Implementation of RDTs is hindered by workflow inefficiencies, resource limitations, and lack of ASPs, which need to be addressed for effective integration.
Interpretation:
Enhancing outpatient ASPs and implementing RDTs can lead to better clinical outcomes, such as reduced hospitalizations and improved patient satisfaction, while also minimizing antibiotic misuse in URI management.
Limitations:
Current RDT implementation is constrained by staffing shortages and reimbursement challenges, which need to be addressed to improve access.
There is a lack of comprehensive evidence demonstrating the impact of RDTs on clinical outcomes and antibiotic prescribing, necessitating further research.
Conclusion:
Future evaluations of RDTs should focus on specific strategies to minimize unnecessary antibiotic prescriptions, such as training for healthcare providers, and expand point-of-care testing to improve antimicrobial stewardship.
Pragmatic cluster randomized crossover study found no statistically significant difference in laboratory-confirmed influenza during the 2023-2024 season
